On par with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1

Genes and Development

Volumn 26, Issue 5, 2012, Pages 417-432

  Luo, Xin ^a,b   Lee Kraus, W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

DNA repair; Inflammation; Poly(ADP ribose) (PAR); Poly(ADP ribose) polymerase 1 (PARP 1); Stress; Transcription

Indexed keywords

BRCA1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEASOME;

ACETYLATION; AGING; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CATALYSIS; CELL DEATH; CELL GRANULE; CELL METABOLISM; CELLULAR STRESS RESPONSE; CELLULAR STRESS SIGNAL; CHEMICAL STRUCTURE; CHROMATIN STRUCTURE; CLINICAL EFFECTIVENESS; DEACETYLATION; DIMERIZATION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME STABILITY; GENE EXPRESSION REGULATION; GENE LOCATION; GENOTOXICITY; HOMEOSTASIS; HUMAN; METABOLIC REGULATION; METABOLIC STRESS; MOLECULARLY TARGETED THERAPY; NITROSATIVE STRESS; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SUMOYLATION; TISSUE INJURY; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UBIQUITINATION;

AGING; ANIMALS; ENZYME ACTIVATION; ENZYME INHIBITORS; GENOME; HOMEOSTASIS; HUMANS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

ANIMALIA;

EID: 84857891632     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.183509.111     Document Type: Article

References (120)

1. Ahel I, Ahel D, Matsusaka T, Clark AJ, Pines J, Boulton SJ, West SC. 2008. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451: 81-85.
2. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO. 2009. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res 37: 3723-3738.
3. Ame JC, Spenlehauer C, de Murcia G. 2004. The PARP super-family. Bioessays 26: 882-893.
4. Andrabi SA, Kang HC, Haince JF, Lee YI, Zhang J, Chi Z, West AB, Koehler RC, Poirier GG, Dawson TM, et al. 2011. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat Med 17: 692-699.
5. Asher G, Reinke H, Altmeyer M, Gutierrez-Arcelus M, Hottiger MO, Schibler U. 2010. Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding. Cell 142: 943-953.
6. Bai P, Houten SM, Huber A, Schreiber V, Watanabe M, Kiss B, de Murcia G, Auwerx J, Menissier-de Murcia J. 2007. Poly(ADP-ribose) polymerase-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid X receptor/peroxisome pro-liferator-activated receptor-g heterodimer. J Biol Chem 282: 37738-37746.
7. Bai P, Canto C, Brunyanszki A, Huber A, Szanto M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, et al. 2011a. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab 13: 450-460.
8. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, et al. 2011b. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13: 461-468.
9. Bakondi E, Catalgol B, Bak I, Jung T, Bozaykut P, Bayramicli M, Ozer NK, Grune T. 2010. Age-related loss of stress-induced nuclear proteasome activation is due to low PARP-1 activity. Free Radic Biol Med 50: 86-92.
10. Bauer PI, Farkas G, Buday L, Mikala G, Meszaros G, Kun E, Farago A. 1992. Inhibition of DNA binding by the phosphor-ylation of poly ADP-ribose polymerase protein catalysed by protein kinase C. Biochem Biophys Res Commun 187: 730- 736.
11. Beckert S, Farrahi F, Perveen Ghani Q, Aslam R, Scheuenstuhl H, Coerper S, Konigsrainer A, Hunt TK, Hussain MZ. 2006. IGF-I-induced VEGF expression in HUVEC involves phosphorylation and inhibition of poly(ADP-ribose)polymerase. Biochem Biophys Res Commun 341: 67-72.
12. Berger F, Lau C, Ziegler M. 2007. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl trans-ferase 1. Proc Natl Acad Sci 104: 3765-3770.
13. Boehler C, Gauthier LR, Mortusewicz O, Biard DS, Saliou JM, Bresson A, Sanglier-Cianferani S, Smith S, Schreiber V, Boussin F, et al. 2011. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc Natl Acad Sci 108: 2783-2788.
14. Brenner JC, Ateeq B, Li Y, Yocum AK, Cao Q, Asangani IA, Patel S, Wang X, Liang H, Yu J, et al. 2011. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 19: 664-678.
15. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917.
16. Buchan JR, Parker R. 2009. Eukaryotic stress granules: The ins and outs of translation. Mol Cell 36: 932-941.
17. Callow MG, Tran H, Phu L, Lau T, Lee J, Sandoval WN, Liu PS, Bheddah S, Tao J, Lill JR, et al. 2011. Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling. PLoS ONE 6: e22595. doi: 10.1371/journal.pone.0022595.
18. Catalgol B, Wendt B, Grimm S, Breusing N, Ozer NK, Grune T. 2010. Chromatin repair after oxidative stress: Role of PARP-mediated proteasome activation. Free Radic Biol Med 48: 673-680.
19. Chaitanya GV, Steven AJ, Babu PP. 2010. PARP-1 cleavage fragments: Signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 8: 31. doi: 10.1186/1478-811X-8-31.
20. Chang P, Coughlin M, Mitchison TJ. 2009. Interaction between Poly(ADP-ribose) and NuMA contributes to mitotic spindle pole assembly. Mol Biol Cell 20: 4575-4585.
21. Chou DM, Adamson B, Dephoure NE, Tan X, Nottke AC, Hurov KE, Gygi SP, Colaiacovo MP, Elledge SJ. 2010. A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage. Proc Natl Acad Sci 107: 18475-18480.
22. Cohen-Armon M, Visochek L, Rozensal D, Kalal A, Geistrikh I, Klein R, Bendetz-Nezer S, Yao Z, Seger R. 2007. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: A link to histone acetylation. Mol Cell 25: 297-308.
23. Cregan SP, Dawson VL, Slack RS. 2004. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785-2796.
24. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. 1999. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342: 249-268.
25. David KK, Andrabi SA, Dawson TM, Dawson VL. 2009. Partha-natos, a messenger of death. Front Biosci 14: 1116-1128.
26. Devalaraja-Narashimha K, Padanilam BJ. 2010. PARP1 deficiency exacerbates diet-induced obesity in mice. J Endocri-nol 205: 243-252.
27. Ditsworth D, Zong WX, Thompson CB. 2007. Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus. J Biol Chem 282: 17845-17854.
28. Erener S, Hesse M, Kostadinova R, Hottiger MO. 2012. Poly(ADP-ribose) polymerase-1 (PARP1) controls adipo-genic gene expression and adipocyte function. Mol Endo-crinol 26: 79-86.
29. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, et al. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921.
30. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, et al. 2009. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134.
31. Ford AL, Lee JM. 2011. Climbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke. Brain Res 1410: 120-121.
32. Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. 2006. Deletion of nicotinamide nucleotide transhydrogenase: A new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes 55: 2153-2156.
33. Frizzell KM, Kraus WL. 2009. PARP inhibitors and the treatment of breast cancer: Beyond BRCA1/2? Breast Cancer Res 11: 111. doi: 10.1186/bcr2451.
34. Frizzell KM, Gamble MJ, Berrocal JG, Zhang T, Krishnakumar R, Cen Y, Sauve AA, Kraus WL. 2009. Global analysis of transcriptional regulation by poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in MCF-7 human breast cancer cells. J Biol Chem 284: 33926-33938.
35. Gagne JP, Hendzel MJ, Droit A, Poirier GG. 2006. The expanding role of poly(ADP-ribose) metabolism: Current challenges and new perspectives. Curr Opin Cell Biol 18: 145-151.
36. Gagne JP, Moreel X, Gagne P, Labelle Y, Droit A, Chevalier-Pare M, Bourassa S, McDonald D, Hendzel MJ, Prigent C, et al. 2009. Proteomic investigation of phosphorylation sites in poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glyco-hydrolase. J Proteome Res 8: 1014-1029.
37. 2+-induced PARP-1 activation and ANF expression are coupled events in cardi-omyocytes. Biochem J 438: 337-347.
38. Gottschalk AJ, Timinszky G, Kong SE, Jin J, Cai Y, Swanson SK, Washburn MP, Florens L, Ladurner AG, Conaway JW, et al. 2009. Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci 106: 13770-13774.
39. Guettler S, Larose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R, Sicheri F. 2011. Structural basis and sequence rules for substrate recognition by tankyrase explain the basis for cherubism disease. Cell 147: 1340-1354.
40. Ha HC, Snyder SH. 1999. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci 96: 13978-13982.
41. Haenni SS, Hassa PO, Altmeyer M, Fey M, Imhof R, Hottiger MO. 2008. Identification of lysines 36 and 37 of PARP-2 as targets for acetylation and auto-ADP-ribosylation. Int J Biochem Cell Biol 40: 2274-2283.
42. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144: 646-674.
43. Hang CT, Yang J, Han P, Cheng HL, Shang C, Ashley E, Zhou B, Chang CP. 2010. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 466: 62-67.
44. Hassa PO, Hottiger MO. 2008. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 13: 3046-3082.
45. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. 2003. Transcriptional coactivation of nuclear factor-kB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278: 45145-45153.
46. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R, Hottiger MO. 2005. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kB-dependent transcription. J Biol Chem 280: 40450-40464.
47. Herranz D, Serrano M. 2010. SIRT1: Recent lessons from mouse models. Nat Rev Cancer 10: 819-823.
48. Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang Y, Wiessner S, et al. 2009. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461: 614-620.
49. Hunter JE, Willmore E, Irving JA, Hostomsky Z, Veuger SJ, Durkacz BW. 2012. NF-kB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene 31: 251-24.
50. Ji Y, Tulin AV. 2009. Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing. Nucleic Acids Res 37: 3501-3513.
51. Ji Y, Tulin AV. 2010. The roles of PARP1 in gene control and cell differentiation. Curr Opin Genet Dev 20: 512-518.
52. Ju BG, Solum D, Song EJ, Lee KJ, Rose DW, Glass CK, Rosenfeld MG. 2004. Activating the PARP-1 sensor component of the groucho/TLE1 corepressor complex mediates a CaMKinase IId-dependent neurogenic gene activation pathway. Cell 119: 815-829.
53. Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG. 2006. A topoisomerase IIb-mediated dsDNA break required for regulated transcription. Science 312: 1798-1802.
54. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M, Fukasawa K. 2007. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol 9: 1175-1183.
55. Kang HC, Lee YI, Shin JH, Andrabi SA, Chi Z, Gagne JP, Lee Y, Ko HS, Lee BD, Poirier GG, et al. 2011. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage. Proc Natl Acad Sci 108: 14103-14108.
56. Kauppinen TM, Chan WY, Suh SW, Wiggins AK, Huang EJ, Swanson RA. 2006. Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc Natl Acad Sci 103: 7136-7141.
57. +-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119: 803-814.
58. + into a nuclear signal. Genes Dev 19: 1951-1967.
59. Koh DW, Dawson TM, Dawson VL. 2005. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52: 5-14.
60. Kotova E, Jarnik M, Tulin AV. 2009. Poly (ADP-ribose) poly-merase 1 is required for protein localization to Cajal body. PLoS Genet 5: e1000387. doi: 10.1371/journal.pgen.1000387.
61. Kotova E, Lodhi N, Jarnik M, Pinnola AD, Ji Y, Tulin AV. 2011. Drosophila histone H2A variant (H2Av) controls poly(ADP-ribose) polymerase 1 (PARP1) activation in chromatin. Proc Natl Acad Sci 108: 6205-6210.
62. Kourtis N, Tavernarakis N. 2011. Cellular stress response pathways and ageing: Intricate molecular relationships. EMBO J 30: 2520-2531.
63. Kraus WL. 2008. Transcriptional control by PARP-1: Chromatin modulation, enhancer-binding, coregulation, and insulation. Curr Opin Cell Biol 20: 294-302.
64. Kraus WL. 2009. New functions for an ancient domain. Nat Struct Mol Biol 16: 904-907.
65. Krishnakumar R, Kraus WL. 2010a. The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Mol Cell 39: 8-24.
66. Krishnakumar R, Kraus WL. 2010b. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 39: 736-749.
67. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. 2008. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319: 819-821.
68. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. 2011. Role of oxidative stress and DNA damage in human carcinogen-esis. Mutat Res 711: 193-201.
69. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. 2011. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 42: 489-499.
70. Levaot N, Voytyuk O, Dimitriou I, Sircoulomb F, Chandrakumar A, Deckert M, Krzyzanowski PM, Scotter A, Gu S, Janmohamed S, et al. 2011. Loss of tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell 147: 1324-1339.
71. Lonkar P, Dedon PC. 2011. Reactive species and DNA damage in chronic inflammation: Reconciling chemical mechanisms and biological fates. Int J Cancer 128: 1999-2009.
72. Lonn P, van der Heide LP, Dahl M, Hellman U, Heldin CH, Moustakas A. 2010. PARP-1 attenuates Smad-mediated transcription. Mol Cell 40: 521-532.
73. Loseva O, Jemth AS, Bryant HE, Schuler H, Lehtio L, Karlberg T, Helleday T. 2010. PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA. J Biol Chem 285: 8054-8060.
74. Luo X, Kraus WL. 2011. A one and a two.expanding roles for poly(ADP-ribose) polymerases in metabolism. Cell Metab 13: 353-355.
75. Mangerich A, Herbach N, Hanf B, Fischbach A, Popp O, Moreno-Villanueva M, Bruns OT, Burkle A. 2010. Inflamma-tory and age-related pathologies in mice with ectopic expression of human PARP-1. Mech Ageing Dev 131: 389-404.
76. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V. 2011. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332: 1443-1446.
77. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, Zhang XD, Bischof O, Seeler JS, Dejean A. 2009. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J 28: 3534-3548.
78. Masutani M, Nakagama H, Sugimura T. 2005. Poly(ADP-ribo-syl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 62: 769-783.
79. Medzhitov R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
80. Mehrotra PV, Ahel D, Ryan DP, Weston R, Wiechens N, Kraehenbuehl R, Owen-Hughes T, Ahel I. 2011. DNA repair factor APLF is a histone chaperone. Mol Cell 41: 46-55.
81. Menissier de Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, Dantzer F, Schreiber V, Ame JC, Dierich A, LeMeur M, et al. 2003. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 22: 2255-2263.
82. Min W, Wang ZQ. 2009. Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential. Front Biosci 14: 1619-1626.
83. Mota RA, Sanchez-Bueno F, Saenz L, Hernandez-Espinosa D, Jimeno J, Tornel PL, Martinez-Torrano A, Ramirez P, Parrilla P, Yelamos J. 2005. Inhibition of poly(ADP-ribose) polymer-ase attenuates the severity of acute pancreatitis and associated lung injury. Lab Invest 85: 1250-1262.
84. Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J, Bille K, Robert C, Bressac-de Paillerets B, Hofman P, et al. 2011. Senescent cells develop a PARP-1 and nuclear factor-kB-associated secretome (PNAS). Genes Dev 25: 1245-1261.
85. Oka S, Kato J, Moss J. 2006. Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase. J Biol Chem 281: 705-713.
86. Pacher P, Szabo C. 2007. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: The therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 25: 235-260.
87. Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, Tempst P, de Murcia G, Evans R, Chambon P, Reinberg D. 2005. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 18: 83-96.
88. Petesch SJ, Lis JT. 2008. Rapid, transcription-independent loss of nucleosomes over a large chromatin domain at Hsp70 loci. Cell 134: 74-84.
89. Petesch SJ, Lis JT. 2012. Activator-induced spread of poly(ADP-ribose) polymerase promotes nucleosome loss at Hsp70. Mol Cell 45: 64-74.
90. Pinnola A, Naumova N, Shah M, Tulin AV. 2007. Nucleosomal core histones mediate dynamic regulation of poly(ADP-ribose) polymerase 1 protein binding to chromatin and induction of its enzymatic activity. J Biol Chem 282: 32511-32519.
91. Piskunova TS, Yurova MN, Ovsyannikov AI, Semenchenko AV, Zabezhinski MA, Popovich IG, Wang ZQ, Anisimov VN. 2008. Deficiency in poly(ADP-ribose) polymerase-1 (PARP-1) accelerates aging and spontaneous carcinogenesis in mice. Curr Gerontol Geriatr Res 2008: 754190. doi: 10.1155/2008/ 754190.
92. Rajamohan SB, Pillai VB, Gupta M, Sundaresan NR, Birukov KG, Samant S, Hottiger MO, Gupta MP. 2009. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 29: 4116-4129.
93. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. 2010. PARP inhibition: PARP1 and beyond. Nat Rev Cancer 10: 293-301.
94. Rouleau M, Saxena V, Rodrigue A, Paquet ER, Gagnon A, Hendzel MJ, Masson JY, Ekker M, Poirier GG. 2011. A key role for poly(ADP-ribose) polymerase 3 in ectodermal specification and neural crest development. PLoS ONE 6: e15834. doi: 10.1371/journal.pone.0015834.
95. Rulten SL, Cortes-Ledesma F, Guo L, Iles NJ, Caldecott KW. 2008. APLF (C2orf13) is a novel component of poly(ADP-ribose) signaling in mammalian cells. Mol Cell Biol 28: 4620-4628.
96. Sala A, La Rocca G, Burgio G, Kotova E, Di Gesu D, Collesano M, Ingrassia AM, Tulin AV, Corona DF. 2008. The nucleosome-remodeling ATPase ISWI is regulated by poly-ADP-ribosylation. PLoS Biol 6: e252. doi: 10.1371/journal.pbio.0060252.
97. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V, Menissier-de Murcia J, de Murcia G. 2002. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 277: 23028-23036.
98. Schreiber V, Dantzer F, Ame JC, de Murcia G. 2006. Poly(ADP-ribose): Novel functions for an old molecule. Nat Rev Mol Cell Biol 7: 517-528.
99. Shall S, de Murcia G. 2000. Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat Res 460: 1-15.
100. Shevalye H, Stavniichuk R, Xu W, Zhang J, Lupachyk S, Maksimchyk Y, Drel VR, Floyd EZ, Slusher B, Obrosova IG. 2010. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. Biochem Pharmacol 79: 1007-1014.
101. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME. 1998. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem 273: 13703-13712.
102. Stilmann M, Hinz M, Arslan SC, Zimmer A, Schreiber V, Scheidereit C. 2009. A nuclear poly(ADP-ribose)-dependent signalosome confers DNA damage-induced IkB kinase activation. Mol Cell 36: 365-378.
103. Telli ML. 2011. PARP inhibitors in cancer: Moving beyond BRCA. Lancet Oncol 12: 827-828.
104. Tennen RI, Chua KF. 2011. Chromatin regulation and genome maintenance by mammalian SIRT6. Trends Biochem Sci 36: 39-46.
105. Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nijmeijer B, Colombelli J, Altmeyer M, Stelzer EH, Scheffzek K, et al. 2009. A macrodomain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat Struct Mol Biol 16: 923-929.
106. Tulin A, Spradling A. 2003. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299: 560-562.
107. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ. 1999. Poly-ADP ribose polymerase activates nuclear protea-some to degrade oxidatively damaged histones. Proc Natl Acad Sci 96: 6223-6228.
108. Underhill C, Toulmonde M, Bonnefoi H. 2011. A review of PARP inhibitors: From bench to bedside. Ann Oncol 22: 268-279.
109. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 9: 509-520.
110. Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, Poirier GG, Dawson VL, Dawson TM. 2011. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci Signal 4: ra20. doi: 10.1126/scisignal.2000902.
111. Wellen KE, Thompson CB. 2010. Cellular metabolic stress: Considering how cells respond to nutrient excess. Mol Cell 40: 323-332.
112. Wesierska-Gadek J, Ranftler C, Schmid G. 2005. Physiological ageing: Role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence. J Physiol Pharmacol 56: 77-88.
113. Yoo YD, Huang CT, Zhang X, Lavaute TM, Zhang SC. 2011. Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway. Stem Cells 29: 1975-1982.
114. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apo-ptosis-inducing factor. Science 297: 259-263.
115. Zerfaoui M, Errami Y, Naura AS, Suzuki Y, Kim H, Ju J, Liu T, Hans CP, Kim JG, Abd Elmageed ZY, et al. 2010. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-medi-ated nuclear export and retention of p65 NF-kB upon TLR4 stimulation. J Immunol 185: 1894-1902.
116. Zhang K, Kaufman RJ. 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455-462.
117. Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM. 2007. c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ 14: 1001-1010.
118. + salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 284: 20408-20417.
119. Zhang Y, Liu S, Mickanin C, Feng Y, Charlat O, Michaud GA, Schirle M, Shi X, Hild M, Bauer A, et al. 2011. RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13: 623-629.
120. Zobeck KL, Buckley MS, Zipfel WR, Lis JT. 2010. Recruitment timing and dynamics of transcription factors at the Hsp70 loci in living cells. Mol Cell 40: 965-975.